Welcome
-
Home
-
Register
-
Login
-
Help/FAQ
-
0 items
Search
Enter keywords, a title or
a report id number below.
In All Categories
---------------------
Telecom & Computing
Business & Finance
Mfg & Construction
Pharma & Healthcare
Consumer & Retail
Gov & Public Sector
Energy & Transport
Country Reports
Company Reports
---------------------
Transcripts
Advanced
Select a currency for use throughout the site
Australia Dollars
Canada Dollars
Euro
Japan Yen
Sweden Kroner
Switzerland Francs
UK Pounds
US Dollars
Viewing report
Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
|
More
Electronic
Hard Copy
CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder Chapter
Espicom Business Intelligence Ltd, Nov 2006, Pages: 84
Description
Table of Contents
Enquire before Buying
Send to a Friend
Send to a Friend
To email a friend details of
CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder Chapter
complete the form below and click on "Send".
*
Required Information
Your Friend's Details
Friend's Full Name
*
Friend's Email Address
*
A message for your Friend
Your Contact Details
Your Name
*
Email Address
*
Customers who bought this item also bought
Pipeline Insight: ADHD - Shire Driving Diversity in ADHD
Commercial And Pipeline Insight: ADHD - Immature Adult Market Continues To Offer Greatest Commercial Potential
U.S. Attention Deficit Hyperactivity Disorder (ADHD) Markets
Adult ADHD - Strattera Grows Up
Stakeholder Insight: ADHD - Prescriber Attention Still Held by Short Acting Stimulant Drugs
The ADD and ADHD Cure: The Natural Way to Treat Hyperactivity and Refocus Your Child
US market size for attention deficit hyperactivity disorder drugs by number of diagnosed and treated ADHD patients, by number of ADHD prescriptions and by dollar value of ADHD pharmaceutical sales; breakout of percent market share, number of prescrip
US market size for attention deficit / hyperactivity disorder drugs by number of diagnosed and treated ADHD patients, number of prescriptions and ADHD drug sales in US dollars for 1999 forecast to 2004, with breakdown of dollar sales, Rx numbers and
Adhd Market: Pestel Analysis and Scenario Based Forecasts
Forecast Insight: Attention-Deficit Hyperactivity Disorder - Shire to stay on top despite drug safety fears and generic competition
Commercial Insight: ADHD - Strattera Reigns Supreme as Branded Stimulants Slump
ADHD & Insomnia Treatments
Top of page
All rights reserved. © Copyright 2009 Research and Markets
1
Terms and conditions
Privacy Policy
Publishers
Employment Opportunities
Site Map
Link to us
Webmaster
